Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jan;37(1):163-77.
doi: 10.1038/npp.2011.216. Epub 2011 Oct 26.

Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation

Affiliations
Review

Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation

Giovanni Addolorato et al. Neuropsychopharmacology. 2012 Jan.

Abstract

Drug addiction represents a major social problem where addicts and alcoholics continue to seek and take drugs despite adverse social, personal, emotional, and legal consequences. A number of pharmacological compounds have been tested in human addicts with the goal of reducing the level or frequency of intake, but these pharmacotherapies have often been of only moderate efficacy or act in a sub-population of humans. Thus, there is a tremendous need for new therapeutic interventions to treat addiction. Here, we review recent interesting studies focusing on gamma-aminobutyric acid receptors, voltage-gated ion channels, and transcranial magnetic stimulation. Some of these treatments show considerable promise to reduce addictive behaviors, or the early clinical studies or pre-clinical rationale suggest that a promising avenue could be developed. Thus, it is likely that within a decade or so, we could have important new and effective treatments to achieve the goal of reducing the burden of human addiction and alcoholism.

PubMed Disclaimer

References

    1. Addolorato G, Caputo F, Capristo E, Colombo G, Gessa GL, Gasbarrini G. Ability of baclofen in reducing alcohol craving and intake: II-preliminary clinical evidence. Alcohol Clin Exp Res. 2000;24:67–71. - PubMed
    1. Addolorato G, Caputo F, Capristo E, Janiri L, Bernardi M, Agabio R, et al. Rapid suppression of alcohol withdrawal syndrome by baclofen. Am J Med. 2002;112:226–229. - PubMed
    1. Addolorato G, Leggio L, Abenavoli L, Agabio R, Caputo F, Capristo E, et al. 2006Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam Am J Med 119276e213–278. - PubMed
    1. Addolorato G, Leggio L, Abenavoli L, Caputo F, Gasbarrini G. Tolerance to baclofen's sedative effect in alcohol-addicted patients: no dissipation after a period of abstinence. Psychopharmacology (Berl) 2005;178:351–352. - PubMed
    1. Addolorato G, Leggio L, Ferrulli A, Cardone S, Bedogni G, Gasbarrini G, and the Baclofen Study Group et al. Dose-response effect of baclofen in reducing daily alcohol intake in alcohol-dependent subjects: secondary analysis of a randomized double-blind placebo controlled trial. Alcohol Alcohol. 2011;46:312–317. - PubMed

MeSH terms